Table 2 Clinical and anatomic parameter outcomes during topical treatment
Mean ± SD | Initial | 0 M | Δ (change) | p* |
|---|---|---|---|---|
Total (n = 42) | ||||
 BCVA (LogMAR) | 0.95 ± 0.39 | 0.8 ± 0.31 | − 0.15 ± 0.12 | < 0.001 |
 CFT (µm) | 606.17 ± 160.37 | 555.07 ± 149.63 | − 51.1 ± 45.9 | < 0.001 |
Nondiabetic (n = 21) | ||||
 BCVA (LogMAR) | 0.74 ± 0.32 | 0.63 ± 0.25 | − 0.11 ± 0.11 | 0.012 |
 CFT (µm) | 537.86 ± 99.91 | 494.43 ± 99.73 | − 43.42 ± 53.66 | 0.012 |
Diabetic w/o DR (n = 21) | ||||
 BCVA (LogMAR) | 1.15 ± 0.35 | 0.98 ± 0.28 | − 0.18 ± 0.11 | 0.012 |
 CFT (µm) | 674.48 ± 181.49 | 615.71 ± 168.01 | − 58.76 ± 36.28 | 0.013 |